Bally’s Corporation (NYSE: BALY; BALY.T) (“Bally’s” or the “Company”) today announced that it has completed the previously ...
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...
JMP Securities lowered the firm’s price target on Haemonetics (HAE) to $100 from $125 and keeps an Outperform rating on the shares. Haemonetics ...